Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works

Alzheimer’s disease

Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works

THE AMYGDALA MODULATES THE CONSOLIDATION OF MEMORIES OF EMOTIONALLY AROUSING EXPERIENCES

McGaugh, J. L. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144157 · Cited by 2,296 · cited 1× · see citing works

A Century of Alzheimer's Disease

Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,106 · see citing works

Oxidative damage and mitochondrial decay in aging.

Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · see citing works

Aβ Oligomers – a decade of discovery

Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · see citing works

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works

The induction of differentiation in teratocarcinoma stem cells by retinoic acid

Strickland, S., & Mahdavi, V. (1978) · Cell · doi:10.1016/0092-8674(78)90008-9 · Cited by 1,420 · see citing works

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347 · see citing works

Inflammation in Neurodegenerative Disease—A Double-Edged Sword

Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

Amyloid β-Protein Fibrillogenesis

Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,139 · see citing works

Systemic inflammation and disease progression in Alzheimer disease

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · see citing works

Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · see citing works

ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050 · see citing works

Retinoic acid in the development, regeneration and maintenance of the nervous system

Maden, M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2212 · Cited by 896 · see citing works

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · see citing works

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768 · see citing works

Molecular basis for amyloid fibril formation and stability

Makin, O. S., Atkins, E. D. T., Sikorski, P., Johansson, J., & Serpell, L. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406847102 · Cited by 649 · see citing works

Involvement of oxidative stress in Alzheimer disease

Nunomura, A., Castellani, R. J., Zhu, X., Moreira, P. I., Perry, G., & Smith, M. A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000228136.58062.bf · Cited by 611 · see citing works

Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

Mufson, E. J., Counts, S., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 589 · see citing works

Neuropathologic changes in Alzheimer's disease.

Wenk, G. L. (2003) · PubMed · Cited by 554 · see citing works

Impaired Mitochondrial Biogenesis Contributes to Mitochondrial Dysfunction in Alzheimer's Disease

Sheng, B., Wang, X.-L., Su, B., Lee, H.-G., Casadesus, G., Perry, G., & Zhu, X.-W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07581.x · Cited by 538 · see citing works

RAR and RXR modulation in cancer and metabolic disease

Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2397 · Cited by 517 · see citing works

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 479 · see citing works

Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation

Leventhal, J. R., Abecassis, M. M., Miller, J., Gallon, L. G., Ravindra, K. V., Tollerud, D. J., King, B. J., Elliott, M. J., Herzig, G. P., Herzig, R. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003509 · Cited by 462 · see citing works

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

Gibson, G. E., Sheu, K. ‐. R., Blass, J. P., Baker, A., Carlson, K., Harding, B. N., & Perrino, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320022009 · Cited by 425 · see citing works

Retinoids regulate stem cell differentiation

Gudas, L. J., & Wagner, J. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22417 · Cited by 395 · see citing works

Oxidative stress increases expression and activity of BACE in NT2 neurons

Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385 · see citing works

Polymorphism in the intermediates and products of amyloid assembly

Kodali, R. B., & Wetzel, R. B. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.01.007 · Cited by 376 · see citing works

Structural Characterization of a Soluble Amyloid β-Peptide Oligomer

Yu, L. P., Edalji, R. P., Harlan, J. E., Holzman, T. F., López, A. R., Labkovsky, B., Hillen, H., Barghorn, S., Ebert, U., Richardson, P. L., et al. (2009) · Biochemistry · doi:10.1021/bi802046n · Cited by 354 · see citing works

Ineffective phagocytosis of amyloid-β by macrophages of Alzheimer's disease patients

Fiala, M., Lin, J., Ringman, J. M., Kermani-Arab, V., Tsao, G., Patel, A. J., Lossinsky, A. S., Graves, M. C., Gustavson, A. R., Sayre, J. W., et al. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7304 · Cited by 328 · see citing works

Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease

Thal, D. R., Walter, J., Saido, T. C., & Fändrich, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1375-y · Cited by 319 · see citing works

A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome

Shi, Y., Kirwan, P., Smith, J., MacLean, G., Orkin, S. H., & Livesey, F. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003771 · Cited by 310 · see citing works

Drug repositioning for Alzheimer's disease

Corbett, A., Pickett, J., Burns, A. S., Corcoran, J. P. T., Dunnett, S. B., Edison, P., Hagan, J. J., Holmes, C., Jones, E., Katona, C., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3869 · Cited by 302 · see citing works

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease

Jaturapatporn, D., Isaac, M. G. E. K. N., McCleery, J. M., & Tabet, N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006378.pub2 · Cited by 299 · see citing works

Deciphering the Genetic Basis of Alzheimer's Disease

Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 293 · see citing works

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

Mann, D. M. A., Lincoln, J., Yates, P. O., Stamp, J., & Toper, S. (1980) · The British Journal of Psychiatry · doi:10.1192/bjp.136.6.533 · Cited by 285 · see citing works

Kinetics and Thermodynamics of Amyloid Fibril Assembly

Wetzel, R. B. (2006) · Accounts of Chemical Research · doi:10.1021/ar050069h · Cited by 284 · see citing works

Retinoic acid signaling pathways in development and diseases

Das, B. C., Thapa, P., Karki, R., Das, S., Mahapatra, S., Liu, T.-C., Torregroza, I., Wallace, D. P., Kambhampati, S., Van Veldhuizen, P., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.025 · Cited by 276 · see citing works

Retinoic Acid Attenuates β-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model

Ding, Y., Qiao, A., Wang, Z., Goodwin, J. S., Lee, E.-S., Block, M. L., Allsbrook, M., McDonald, M. P., & Fan, G.-H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3153-08.2008 · Cited by 269 · see citing works

Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type

Iversen, L. L., Rossor, M. N., Reynolds, G. P., Hills, R., Roth, M., Mountjoy, C. Q., Foote, S. L., Morrison, J. H., & Bloom, F. E. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90171-4 · Cited by 264 · see citing works

Cerebrovascular Effects of Apolipoprotein E: Implications for Alzheimer Disease

Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2152 · Cited by 263 · see citing works

Acute Impairment of Mitochondrial Trafficking by β-Amyloid Peptides in Hippocampal Neurons

Rui, Y., Tiwari, P., Xie, Z., & Zheng, J. Q. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3231-06.2006 · Cited by 251 · see citing works

Towards regenerative therapy for cardiac disease

Ptaszek, L. M., Mansour, M., Ruskin, J. N., & Chien, K. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60075-0 · Cited by 242 · see citing works

The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics

Carreiras, M. C., Mendes, E., Perry, M. D. J., Francisco, A., & Marco‐Contelles, J. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990135 · Cited by 242 · see citing works

Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives

Anguiano, J., Garner, T. P., Mahalingam, M., Das, B. C., Gavathiotis, E., & Cuervo, A. M. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1230 · Cited by 226 · see citing works

Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care

Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., Miguel, Z. D., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 224 · see citing works

Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors.

Peterson, C., & Goldman, J. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2758 · Cited by 221 · see citing works

Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor–retinoid X receptor family

Samad, T. A., Krężel, W., Chambon, P., & Borrelli, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14349 · Cited by 219 · see citing works

Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils

Habicht, G., Haupt, C., Friedrich, R. P., Hortschansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellermann, G. P., Brodhun, M., Götz, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703793104 · Cited by 216 · see citing works

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients

Štorga-Tomić, D., Vrečko, K., Birkmayer, J. G. D., & Reibnegger, G. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12256-7 · Cited by 209 · see citing works

Recent developments in Alzheimer's disease therapeutics

Rafii, M., & Aisen, P. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-7 · Cited by 204 · see citing works

Retinoic acid inhibits expression of TNF-? and iNOS in activated rat microglia

Dheen, S. T., Jun, Y., Yan, Z., Tay, S. S. W., & Ling, E. (2004) · Glia · doi:10.1002/glia.20153 · Cited by 199 · see citing works

Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain

Corcoran, J. P. T., So, P. L., & Maden, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03563.x · Cited by 190 · see citing works

Evidence for defective retinoid transport and function in late onset Alzheimer's disease

Goodman, A. B., & Pardee, A. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437937100 · Cited by 184 · see citing works

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

Dias, K. S. T., & Viegas, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x1203140511153200 · Cited by 174 · see citing works

Mitochondria-targeted catalase reduces abnormal APP processing, amyloid production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension

Mao, P., Mańczak, M., Calkins, M. J., Truong, Q., Reddy, T. P., Reddy, A. P., Shirendeb, U. P., Lo, H., Rabinovitch, P. S., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds128 · Cited by 174 · see citing works

Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor

Yoshikawa, K., Aizawa, T., & Hayashi, Y. (1992) · Nature · doi:10.1038/359064a0 · Cited by 173 · see citing works

Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer’s disease

Upadhaya, A. R., Kosterin, I., Kumar, S., Arnim, C. A. F. V., Yamaguchi, H., Fändrich, M., Walter, J., & Thal, D. R. (2014) · Brain · doi:10.1093/brain/awt362 · Cited by 165 · see citing works

Coordinated Up-regulation of Choline Acetyltransferase and Vesicular Acetylcholine Transporter Gene Expression by the Retinoic Acid Receptor α, cAMP, and Leukemia Inhibitory Factor/Ciliary Neurotrophic Factor Signaling Pathways in a Murine Septal Cell Line

Berse, B., & Blusztajn, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22101 · Cited by 164 · see citing works

Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level

Ahlemeyer, B., Bauerbach, E., Plath, M., Steuber, M., Heers, C., Tegtmeier, F., & Krieglstein, J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00495-6 · Cited by 162 · see citing works

A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease

Reinikainen, K. J., Paljärvi, L., Huuskonen, M., Soininen, H. S., Laakso, M., & Riekkinen, P. J. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90179-7 · Cited by 154 · see citing works

Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

Fitz, N. F., Cronican, A. A., Lefterov, I., & Koldamova, R. (2013) · Science · doi:10.1126/science.1235809 · Cited by 151 · see citing works

Comment on “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.”

Price, A. R., Xu, G., Siemienski, Z. B., Smithson, L. A., Borchelt, D. R., Golde, T. E., & Felsenstein, K. M. (2013) · Science · doi:10.1126/science.1234089 · Cited by 138 · see citing works

Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease

Goodman, A. B. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20784 · Cited by 137 · see citing works

Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

Veeraraghavalu, K., Zhang, C., Miller, S., Hefendehl, J. K., Rajapaksha, T. W., Ulrich, J., Jucker, M., Holtzman, D. M., Tanzi, R. E., Vassar, R., et al. (2013) · Science · doi:10.1126/science.1235505 · Cited by 133 · see citing works

Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro

Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.035 · Cited by 131 · see citing works

Nuclear receptors as therapeutic targets for Alzheimer's disease

Mandrekar-Colucci, S., & Landreth, G. E. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.594043 · Cited by 126 · see citing works

Retinoic acid receptor β2 promotes functional regeneration of sensory axons in the spinal cord

Wong, L., Yip, P. K., Battaglia, A. A., Grist, J., Corcoran, J. P. T., Maden, M., Azzouz, M., Kingsman, S. M., Kingsman, A. J., Mazarakis, N. D., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1622 · Cited by 124 · see citing works

All-transretinoic acid as a novel therapeutic strategy for Alzheimer’s disease

Lee, H. P., Casadesús, G., Zhu, X., Lee, H., Perry, G. L., Smith, M. A., Gustaw‐Rothenberg, K., & Lerner, A. J. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.86 · Cited by 120 · see citing works

Carotenoids and Alzheimer’s Disease: An insight into therapeutic role of retinoids in animal models

Obulesu, M., Dowlathabad, M. R., & Bramhachari, P. V. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.04.004 · Cited by 115 · see citing works

Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer

Esteva, F. J., Glaspy, J. A., Baidas, S. M., Laufman, L. R., Hutchins, L. F., Dickler, M. N., Tripathy, D., Cohen, R., DeMichele, A. M., Yocum, R. C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.068 · Cited by 115 · see citing works

Assessing the contribution of inflammation in models of Alzheimer's disease

Johnston, H. R., Boutin, H., & Allan, S. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390886 · Cited by 112 · see citing works

Retinoids and spinal cord development.

Maden, M. (2006) · Journal of Neurobiology · doi:10.1002/neu.20248 · Cited by 111 · see citing works

ADDLs and the signaling web that leads to Alzheimer’s disease

Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 111 · see citing works

Retinoic acid receptor β2 and neurite outgrowth in the adult mouse spinal cord in vitro

Corcoran, J. P. T., So, P.-L., Barber, R. D., Vincent, K. J., Mazarakis, N. D., Mitrophanous, K. A., Kingsman, S. M., & Maden, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00046 · Cited by 107 · see citing works

Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators

le Maire, A., Álvarez, S., Shankaranarayanan, P., de Lera, Á. R., Bourguet, W., & Gronemeyer, H. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436687 · Cited by 106 · see citing works

Synthetic Retinoids: Recent Developments Concerning Structure and Clinical Utility

Kagechika, H., & Shudo, K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0581821 · Cited by 106 · see citing works

Post‐training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems

LaLumiere, R. T., Nguyen, L. T., & McGaugh, J. L. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03744.x · Cited by 105 · see citing works

Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1

Lahiri, D. K., & Nall, C. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00078-7 · Cited by 104 · see citing works

Piecing Together Alzheimer's

George‐Hyslop, P. S. (2000) · Scientific American · doi:10.1038/scientificamerican1200-76 · Cited by 99 · see citing works

Microglia in Alzheimer's Disease: It's All About Context

Weitz, T. M., & Town, T. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/314185 · Cited by 95 · see citing works

Familial Alzheimer’s Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization

Gessel, M. M., Bernstein, S. L., Kemper, M., Teplow, D. B., & Bowers, M. T. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300050d · Cited by 93 · see citing works

A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

Dragnev, K. H., Petty, W. J., Shah, S. J., Lewis, L. D., Black, C. C., Memoli, V. A., Nugent, W. C., Hermann, T. W., Negro-Vilar, A. F., Rigas, J. R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1836 · Cited by 92 · see citing works

Tamibarotene: A Candidate Retinoid Drug for Alzheimer’s Disease

Fukasawa, H., Nakagomi, M., Yamagata, N., Katsuki, H., Kawahara, K., Kitaoka, K., Miki, T., & Shudo, K. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00314 · Cited by 91 · see citing works

Towards Retinoid Therapy for Alzheimers Disease

Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91 · see citing works

Regulation of Acetylcholinesterase Expression during Neuronal Differentiation

Coleman, B. A., & Taylor, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4410 · Cited by 90 · see citing works

The role of the metabolic lesion in Alzheimer's disease

Blass, J. P., Gibson, G. E., & Hoyer, S. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4312 · Cited by 90 · see citing works

Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells

Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., & Govoni, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00536-3 · Cited by 89 · see citing works

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling

Katsuki, H., Kurimoto, E., Takemori, S., Kurauchi, Y., Hisatsune, A., Isohama, Y., Izumi, Y., Kume, T., Shudo, K., & Akaike, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06171.x · Cited by 88 · see citing works

Vitamin A has Anti-Oligomerization Effects on Amyloid-β In Vitro

Takasaki, J., Ono, K., Yoshiike, Y., Hirohata, M., Ikeda, T., Morinaga, A., Takashima, A., & Yamada, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110455 · Cited by 84 · see citing works

Tamibarotene

Miwako, I., & Kagechika, H. (2007) · Drugs of today · doi:10.1358/dot.2007.43.8.1072615 · Cited by 84 · see citing works

Amyloid β inhibits retinoic acid synthesis exacerbating A lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist

Goncalves, M. B. C. V., Clarke, E. E., Hobbs, C., Malmqvist, T., Deacon, R. M. J., Jack, J., & Corcoran, J. P. T. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12142 · Cited by 81 · see citing works

Regulation of the tyrosine hydroxylase and dopamine β‐hydroxylase genes by the transcription factor AP‐2

Kim, H., Hong, S. J., LeDoux, M. S., & Kim, K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00044.x · Cited by 80 · see citing works

Retinoic acid receptor‐α signalling antagonizes both intracellular and extracellular amyloid‐β production and prevents neuronal cell death caused by amyloid‐β

Jarvis, C. I., Goncalves, M. B. C. V., Clarke, E. E., Dogruel, M., Kalindjian, S. B., Thomas, S. A., Maden, M., & Corcoran, J. P. T. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07426.x · Cited by 78 · see citing works

Striatal dopamine receptors in Alzheimer-type dementia

Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, J. A., & Markakis, D. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90341-0 · Cited by 77 · see citing works

Behavioral and neurobiological markers of Alzheimer’s disease in Ts65Dn mice: effects of estrogen

Hunter, C. L., Bimonte‐Nelson, H. A., Nelson, M., Eckman, C. B., & Granholm, A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.010 · Cited by 77 · see citing works

Retinoic Acid Synthesis Promotes Development of Neural Progenitors from Mouse Embryonic Stem Cells by Suppressing Endogenous, Wnt-Dependent Nodal Signaling

Engberg, N., Kahn, M., Petersen, D. R., Hansson, M. D., & Serup, P. (2010) · Stem Cells · doi:10.1002/stem.479 · Cited by 76 · see citing works

Reduced striatal dopamine receptors in Alzheimer's disease

Pizzolato, G., Chierichetti, F., Fabbri, M., Cagnin, A., Dam, M., Ferlin, G., & Battistin, L. (1996) · Neurology · doi:10.1212/wnl.47.4.1065 · Cited by 72 · see citing works

Properties of retinoids

Barua, A. B., & Furr, H. C. (1998) · Molecular Biotechnology · doi:10.1007/bf02760863 · Cited by 71 · see citing works

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence

Tousi, B. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s61309 · Cited by 70 · see citing works

PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD

Kemppainen, N. M., Ruottinen, H., Någren, K., & Rinne, J. O. (2000) · Neurology · doi:10.1212/wnl.55.2.205 · Cited by 70 · see citing works

Vitamin A/Retinol and Maintenance of Pluripotency of Stem Cells

Khillan, J. S. (2014) · Nutrients · doi:10.3390/nu6031209 · Cited by 68 · see citing works

Defined concentrations of a posteriorizing signal are critical for MafB/Kreisler segmental expression in the hindbrain

Grapin‐Botton, A., Bonnin, M.-A., Sieweke, M. H., & Douarin, N. M. L. (1998) · Development · doi:10.1242/dev.125.7.1173 · Cited by 68 · see citing works

Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in β-amyloid deposits in the cerebral cortex of vitamin A deprived rats

Husson, M., Enderlin, V., Delacourte, A., Ghenimi, N., Alfos, S., Pallet, V., & Higueret, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.008 · Cited by 67 · see citing works

Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats

Veng, L., Granholm, A. C., & Rose, G. M. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00219-1 · Cited by 67 · see citing works

Amyloid Plaque and Neurofibrillary Tangle Pathology in a Regulatable Mouse Model of Alzheimer's Disease

Paulson, J. B., Ramsden, M., Forster, C. L., Sherman, M. A., McGowan, E. M., & Ashe, K. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080175 · Cited by 67 · see citing works

Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation

Christie, V. B., Barnard, J. H., Batsanov, A. S., Bridgens, C. E., Cartmell, E. B., Collings, J. C., Maltman, D. J., Redfern, C. P. F., Marder, T. B., Przyborski, S. A., et al. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b808574a · Cited by 65 · see citing works

Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats

Santucci, A. C., Kanof, P. D., & Haroutunian, V. H. (1989) · Psychopharmacology · doi:10.1007/bf00634455 · Cited by 63 · see citing works

Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species

Yang, Y., Quitschke, W. W., & Brewer, G. J. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00164-8 · Cited by 62 · see citing works

Analysis of Retinoids and Carotenoids: Problems Resolved and Unsolved

Furr, H. C. (2004) · Journal of Nutrition · doi:10.1093/jn/134.1.281s · Cited by 62 · see citing works

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

Webster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62 · see citing works

α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy

Fahrenholz, F., & Postina, R. (2006) · Neurodegenerative Diseases · doi:10.1159/000095264 · Cited by 59 · see citing works

All‐trans‐ and 9‐cis‐Retinoic Acid Enhance the Cholinergic Properties of a Murine Septal Cell Line: Evidence that the Effects Are Mediated by Activation of Retinoic Acid Receptor‐α

Pedersen, W. A., Berse, B., Schüler, U., Wainer, B. H., & Blusztajn, J. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010050.x · Cited by 59 · see citing works

Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer's disease.

Saraiva, A., Borges, M. M., Madeira, M. D., Tavares, M. A., & Paula-Barbosa, M. M. (1985) · PubMed · Cited by 57 · see citing works

Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice

Upadhaya, A. R., Capetillo‐Zarate, E., Kosterin, I., Abramowski, D., Kumar, S., Yamaguchi, H., Walter, J., Fändrich, M., Staufenbiel, M., & Thal, D. R. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.032 · Cited by 54 · see citing works

Regulation of secretases by all‐trans‐retinoic acid

Koryakina, A., Aeberhard, J., Kiefer, S., Hamburger, M. O., & Küenzi, P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06992.x · Cited by 52 · see citing works

Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.

Zitnik, R. J., Kotloff, R. M., Latifpour, J., Zheng, T., Whiting, N. L., Schwalb, J. M., & Elias, J. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1419 · Cited by 51 · see citing works

Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)SL Mice

Lull, M. E., Levesque, S., Surace, M. J., & Block, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020153 · Cited by 51 · see citing works

Cholinergic differentiation of cultured sympathetic neurons induced by retinoic acid

Kobayashi, M., Matsuoka, I., & Kurihara, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80204-1 · Cited by 50 · see citing works

Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid

Kaur, C., Sivakumar, V., Dheen, S. T., & Ling, E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.025 · Cited by 48 · see citing works

Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors

Satoh, J., & Kuroda, Y. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00349.x · Cited by 47 · see citing works

Retinoids for treatment of Alzheimer’s disease

Lerner, A. J., Gustaw‐Rothenberg, K., Smyth, S., & Casadesus, G. (2012) · BioFactors · doi:10.1002/biof.196 · Cited by 44 · see citing works

The Wittig Reaction

Maercker, A. (2011) · Organic reactions · doi:10.1002/0471264180.or014.03 · Cited by 43 · see citing works

Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease

Zhong, Y., Wu, Y., Liu, R., Li, Z., Chen, Y., Evans, T., Chuang, P. Y., Das, B. C., & He, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027945 · Cited by 42 · see citing works

Characterization of the cholinergic neuronal differentiation of the human neuroblastoma cell line LA-N-5 after treatment with retinoic acid

Hill, D. P., & Robertson, K. A. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00076-x · Cited by 41 · see citing works

Retinoic acid isomers protect hippocampal neurons from amyloid-β induced neurodegeneration

Sahin, M., Karaüzüm, S. B., Perry, G., Smith, M. A., & Alicigüzel, Y. (2005) · Neurotoxicity Research · doi:10.1007/bf03036453 · Cited by 41 · see citing works

Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines.

Melino, G., Draoui, M., Bernardini, S., Bellincampi, L., Reichert, U., & Cohen, P. (1996) · PubMed · Cited by 41 · see citing works

Specific Soluble Oligomers of Amyloid-β Peptide Undergo Replication and Form Non-fibrillar Aggregates in Interfacial Environments

Kumar, A., Paslay, L. C., Lyons, D. F., Morgan, S. E., Correia, J. J., & Rangachari, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355156 · Cited by 40 · see citing works

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li, C., Ebrahimi, A., & Schluesener, H. J. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.09.002 · Cited by 39 · see citing works

Anti‐inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes

Kampmann, E., Johann, S., van Neerven, S., Beyer, C., & Mey, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05395.x · Cited by 37 · see citing works

Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression

Ahlemeyer, B., H�hne, R., & Krieglstein, J. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6 · Cited by 34 · see citing works

RECENT DEVELOPMENTS IN ALZHEIMER’S DISEASE

Cras, P. P. (2001) · Acta Clinica Belgica · doi:10.1179/acb.2001.040 · Cited by 33 · see citing works

Peripheral cholesterol metabolic disorders and Alzheimer s disease

Ledesma, M. D. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e368 · Cited by 33 · see citing works

Inhibition of IL-1-Induced IL-6 Production by Synthetic Retinoids

Kagechika, H., Kawachi, E., Fukasawa, H., Saito, G., Iwanami, N., Umemiya, H., Hashimoto, Y., & Shudo, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6087 · Cited by 32 · see citing works

Peripheral cholesterol, metabolic disorders and Alzheimer's disease.

Ledesma, M. D., & Dotti, C. (2012) · Frontiers in Bioscience · doi:10.2741/368 · Cited by 31 · see citing works

The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases

Peng, J., & Zeng, X.-M. (2011) · Stem cell research & therapeutics · doi:10.1186/scrt73 · Cited by 30 · see citing works

Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention

Hampel, H. J. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000579 · Cited by 30 · see citing works

Retinoid Receptors in Inflammatory Responses: A Potential Target for Pharmacology

Kuenzli, S., Tran, C., & Saurat, J. ‐. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010042634587 · Cited by 29 · see citing works

Regenerative Medicine for Skin Diseases: iPS Cells to the Rescue

Uitto, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.2 · Cited by 28 · see citing works

Steric Hindrance between Chromophore Substituents as the Driving Force of Rhodopsin Photoisomerization: 10‐Methyl‐13‐Demethyl Retinal Containing Rhodopsin

Koch, D., & Gärtner, W. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb01896.x · Cited by 26 · see citing works

Immunodetection of protein composition in cerebral amyloid extracts in Alzheimer's disease: Enrichment of retinol-binding protein

Maury, C. P. J., & Teppo, A. M. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90156-0 · Cited by 23 · see citing works

Regenerative therapy for retinal disorders.

Daftarian, N., Kiani, S., & Zahabi, A. (2010) · PubMed Central · Cited by 18 · see citing works

Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer type.

Pinessi, L., Rainero, I., Gennaro, T. D., Gentile, S., Portaleone, P., & Bergamasco, B. (1987) · PubMed · Cited by 18 · see citing works

Application of Regenerative Medicine for Kidney Diseases

Yokoo, T., Fukui, A., & Kobayashi, E. (2007) · Organogenesis · doi:10.4161/org.3.1.3961 · Cited by 10 · see citing works

The growth-supporting activity of a retinoidal benzoic acid derivative and 4,4-difluororetinoic acid

Stephens-Jarnagin, A., Miller, D. A., & DeLuca, H. F. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90248-6 · Cited by 10 · see citing works

Are Retinoids a Promise for Alzheimer's Disease Management?

Carratù, M. R., Marasco, C., Signorile, A., Scuderi, C., & Steardo, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712804485700 · Cited by 9 · see citing works

Basic biology and therapeutic application of stem cells in various human and animal diseases

Dubie, T., Admassu, B., Tessema, T. S., & Shiferaw, H. (2014) · Journal of Cell Biology and Genetics · doi:10.5897/jcbg2014.0039 · Cited by 7 · see citing works

NEWS FROM THE AAN ANNUAL MEETING

Collins, T. R. (2014) · Neurology Today · doi:10.1097/01.nt.0000452276.24201.20 · Cited by 1 · see citing works

Role of Cholinergic Signaling in Alzheimer’s Disease

Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F. (2022) · Molecules · doi:10.3390/molecules27061816 · Cited by 922 · see citing works

Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine

Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138 · see citing works

The Role of Vitamins in Neurodegenerative Disease: An Update

Nand, S., Singh, P., Steinbusch, H. W. M., Vamanu, E., Ashraf, G. M., & Singh, M. P. (2021) · Biomedicines · doi:10.3390/biomedicines9101284 · Cited by 126 · see citing works

Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease

Ray, S., Das, B. C., & Dasgupta, S. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.259604 · Cited by 90 · see citing works

ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker

Manzine, P. R., Ettcheto, M., Cano, A. C., Busquets, O., Marcello, E. E., Pelucchi, S., Luca, M. D., Endres, K., Olloquequi, J., Camins, A., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108661 · Cited by 83 · see citing works

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer’s Disease

Li, R., Zhang, Y., Rasool, S., Geetha, T., & Babu, J. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8165707 · Cited by 72 · see citing works

Retinoic Acid Is Required for Neural Stem and Progenitor Cell Proliferation in the Adult Hippocampus

Mishra, S., Kelly, K. K., Rumian, N. L., & Siegenthaler, J. A. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.024 · Cited by 69 · see citing works

Modulation of Benzo[a]Pyrene Induced Anxiolytic-Like Behavior by Retinoic Acid in Zebrafish: Involvement of Oxidative Stress and Antioxidant Defense System

Mohanty, R., Das, S. K., & Patri, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9694-5 · Cited by 49 · see citing works

A signature of renal stress resistance induced by short-term dietary restriction, fasting, and protein restriction

Jongbloed, F., Saat, T. C., Verweij, M., Payán‐Gómez, C., Hoeijmakers, J. H. J., van den Engel, S., van Oostrom, C. T., Ambagtsheer, G., Imholz, S., Pennings, J. L. A., et al. (2017) · Scientific Reports · doi:10.1038/srep40901 · Cited by 43 · see citing works

Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease

Behl, T., Kaur, D., Sehgal, A., Singla, R. K., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976799 · Cited by 42 · see citing works

Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets

Khan, A., Corbett, A., & Ballard, C. G. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1326818 · Cited by 42 · see citing works

Dietary vitamin A supplementation prevents early obesogenic diet-induced microbiota, neuronal and cognitive alterations

Biyong, E. F., Alfos, S., Dumetz, F., Helbling, J., Aubert, A., Brossaud, J., Foury, A., Moisan, M., Layé, S., Richard, E., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00723-z · Cited by 42 · see citing works

Microbial pathogens induce neurodegeneration in Alzheimer’s disease mice: protection by microglial regulation

Ganz, T., Fainstein, N., Elad, A., Lachish, M., Goldfarb, S., Einstein, O., & Ben‐Hur, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02369-8 · Cited by 30 · see citing works

The Synthetic Retinoid Acitretin Increases IL-6 in the Central Nervous System of Alzheimer Disease Model Mice and Human Patients

Guilherme, M. D. S., Stoye, N. M., Rose‐John, S., Garbers, C., Fellgiebel, A., & Endres, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00182 · Cited by 27 · see citing works

Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies

Biyong, E. F., Tremblay, C., Leclerc, M., Caron, V., Alfos, S., Helbling, J., Rodriguez, L., Pernet, V., Bennett, D. A., Pallet, V., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105542 · Cited by 27 · see citing works

Peptides derived from the knuckle epitope of BMP-9 induce the cholinergic differentiation and inactivate GSk3beta in human SH-SY5Y neuroblastoma cells

Lauzon, M.-A., Drevelle, O., & Faucheux, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-04835-x · Cited by 26 · see citing works

Effects of nutrient and bioactive food components on Alzheimer's disease and epigenetic

Celik, E., & Şanlıer, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1359488 · Cited by 25 · see citing works

Implication of Adult Hippocampal Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches

Essa, H., Peyton, L., Hasan, W., León, B. E., & Choi, D. (2022) · Cells · doi:10.3390/cells11020286 · Cited by 25 · see citing works

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease

Flieger, J., Forma, A., Flieger, W., Flieger, M., Gawlik, P. J., Dzierżyński, E., Maciejewski, R., Teresiński, G., & Baj, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168982 · Cited by 23 · see citing works

Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?

Endres, K. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321163705 · Cited by 22 · see citing works

Scavenging of Retinoid Cation Radicals by Urate, Trolox, and α-, β-, γ-, and δ-Tocopherols

Rôżanowska, M., Edge, R., Land, E. J., Navaratnam, S., Sarna, T., & Truscott, T. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112799 · Cited by 22 · see citing works

Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer’s Disease

Muraleedharan, A., & Ray, S. K. (2024) · Brain Sciences · doi:10.3390/brainsci14010096 · Cited by 19 · see citing works

Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients

Kridin, K., Linder, D., Shalom, G., Piaserico, S., Babaev, M., Freud, T., Comaneshter, D. S., & Cohen, A. D. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3595 · Cited by 17 · see citing works

Nuclear receptor binding factor 2 (NRBF2) is required for learning and memory

Ouyang, X., Ahmad, I., Johnson, M. S., Redmann, M., Craver, J., Wani, W. Y., Benavides, G. A., Chacko, B. K., Li, P., Young, M. E., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0433-4 · Cited by 13 · see citing works

A Systematic Analysis Revealed the Potential Gene Regulatory Processes of ATRA‐Triggered Neuroblastoma Differentiation and Identified a Novel RA Response Sequence in the NTRK2 Gene

Guo, L., Lin, W. J., Zhang, Y., & Wang, J. (2020) · BioMed Research International · doi:10.1155/2020/6734048 · Cited by 9 · see citing works

Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes?

Ashok, A., Naaz, S., Kota, L. N., Sen, S., Purushottam, M., Faruq, M., Kumari, R., Yadav, V. K., Kannan, R., Jain, S., et al. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.08.010 · Cited by 8 · see citing works

Role of Carotenoids in Neurological Diseases

Ahmed, S., Khan, S. T., Aziz, A., Gul, S., Buvnariu, L., & Zia‐Ul‐Haq, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-46459-2_16 · Cited by 8 · see citing works

How Do Retinoids Affect Alzheimer’s Disease and Can They Be Novel Drug Candidates?

Alsharief, M. (2024) · Cureus · doi:10.7759/cureus.57548 · Cited by 8 · see citing works

MicroRNA miR-155-5p knockdown attenuates Angiostrongylus cantonensis-induced eosinophilic meningitis by downregulating MMP9 and TSLP proteins

Zhou, X., Zhang, J., Liu, J., Guo, J., Wei, Y. Q., Li, J., He, P., Lan, T., Peng, L., & Li, H. (2020) · International Journal for Parasitology · doi:10.1016/j.ijpara.2020.07.013 · Cited by 7 · see citing works

All-trans retinoic acid reduces mammalian target of rapamycin via a Sirtuin1-dependent mechanism in neurons

Guo, Y., Zhang, H., Chen, X., & Liu, Y. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001672 · Cited by 6 · see citing works

The protective effects of natural product tunicatachalcone against neuroinflammation via targeting RIPK2 in microglia BV-2 cells stimulated by LPS

Wen, R., Lv, J., Jia, P., Yang, W., Wang, N., Wu, X., Zhong, X., & Liu, Y. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116916 · Cited by 6 · see citing works

The Role of Tau Protein in Diseases

Das Bhaskar, C. (2018) · Annals of Advances in Chemistry · doi:10.29328/journal.aac.1001010 · Cited by 6 · see citing works

Integrating artificial intelligence with small molecule therapeutics and precision medicine for neurochemical understanding of Alzheimer’s diseases

Alshehri, Z. S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.055 · Cited by 5 · see citing works

Re‐remembering the influence of randomized β‐carotene on cognitive decline

Kopec, R. E., Chasman, D. I., Okereke, O. I., & Sesso, H. D. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13018 · Cited by 5 · see citing works

Natural Inhibition of β-secretase in Alzheimer’s Disease by Medicinal Plants

Altaf, A., Akhlaq, M., Uddin, J., Khan, A., Al‐Harrasi, A., Ullah, F., & Ali, F. (2022) · Phytopharmacological communications. · doi:10.55627/ppc.002.01.0042 · Cited by 4 · see citing works

Pouteria sapota (Red Mamey Fruit): Chemistry and Biological Activity of Carotenoids

Rao, K. S. J., Lakey‐Beitia, J., Vasquez, V., Mojica-Flores, R., C., A. L. F., Murillo, E., & Hegde, M. L. (2021) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207324666210301093711 · Cited by 4 · see citing works

Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses

Yu, K., Jiang, R., Zhou, D., & Zhao, Z. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251344572 · Cited by 3 · see citing works

All-trans Retinoic Acid has Limited Therapeutic Effects on Cognition and Hippocampal Protein Expression After Controlled Cortical Impact

Svirsky, S. E., Ranellone, N. S., Parry, M., Holets, E., Henchir, J. J., Li, Y., Carlson, S. W., & Dixon, C. E. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.021 · Cited by 3 · see citing works

11C-Labeling of acyclic retinoid peretinoin by rapid C-[11C]methylation to disclose novel brain permeability and central nervous system activities hidden in antitumor agent

Suzuki, K., Koyama, H., Nakamura, N., Kimura, Y., Ogata, A., Ikenuma, H., Ishii, H., Zhang, M., Kawamura, K., Minamimoto, T., et al. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129212 · Cited by 2 · see citing works

In Silico Pharmacological and Pharmacokinetic Study of Marmeline From Bael Fruit for the Treatment of Alzheimer’s Disease

Ongtanasup, T., Jampa, O., Suwannakul, N., & Eawsakul, K. (2025) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/6634761 · Cited by 2 · see citing works

Unraveling the Intricacies: The Role of miRNAs in the Progression and Initiation of Alzheimer's Disease

Amerizadeh, F., & Farzadifar, E. (2025) · Current Alzheimer Research · doi:10.2174/0115672050374376250416044512 · Cited by 2 · see citing works

A possible role of transthyretin in the biological mechanism of regulatory peptide neuroprotection

V’yunova, T. V., Medvedeva, E. V., Андреева, Л. А., Dergunova, L. V., Limborska, S. A., & Myasoedov, N. F. (2016) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416816030101 · Cited by 2 · see citing works

TUNEL-n-DIFL Method for Detection and Estimation of Apoptosis Specifically in Neurons and Glial Cells in Mixed Culture and Animal Models of Central Nervous System Diseases and Injuries

Ray, S. K. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_1 · Cited by 2 · see citing works

Synthetic Retinoids for the Modulation of Genomic and Nongenomic Processes in Neurodegenerative Diseases

Butler, A. M., Chisholm, D. R., Tomlinson, C. W. E., Khatib, T., Clark, J., Wan, S., Coveney, P. V., Greig, I. R., McCaffery, P. J. A., Pohl, E., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c00934 · Cited by 1 · see citing works

Nutrients and bioactive compounds as modifiers of neurodegenerative trajectories: molecular mechanisms, translational barriers, and precision nutrition

Singh, G., Singh, G., Shreya, Kumari, A., & Aran, K. R. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1819432 · Cited by 1 · see citing works

Nutrition and Central Nervous System

Álvarez, S. M., Gómez, N. N., Navigatore-Fonzo, L., Sanchez, E. S., & Giménez, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_35 · Cited by 1 · see citing works

Vitamin a concentrations in Iraqi patients attending Ibn-Al Haitham Eye Hospital

Ahmed, M. H. (2023) · AIP conference proceedings · doi:10.1063/5.0151098 · Cited by 1 · see citing works

Alzheimer’s Disease Neuroprotection: Associated Receptors

Câmara, A. B. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91918

Role of Phytochemicals, Proteins and Associated Receptors in Alzheimer’s Disease

Rana, K. (2021) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2021.34724

Possible role of transthyretin in the biological mechanism of the regulatory peptide neuroprotection

V’yunova, T. V., Medvedeva, E. V., Андреева, Л. А., Dergunova, L. V., Limborska, S. A., & Myasoedov, N. F. (2016) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.18821/0208-0613-2016-34-3-104-109

All-Trans Retinoic Acid Dose Response to Evaluate Therapeutic Effects on Cognition and Hippocampal Protein Expression after Controlled Cortical ImpactPreprint

Svirsky, S. E., Ranellone, N. S., Parry, M., Holets, E., Henchir, J. J., Li, Y., Carlson, S. W., & Dixon, C. E. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4113853

Impact of vitamin A on the risk of mild cognitive impairment and Alzheimer's disease pathology in high‐fat‐diet–treated APP/PS1 mice

Wang, X., Guo, Y., Li, P., Ma, X., Xu, J., Liu, L., Liu, Y., Ren, X., Wang, Y., Meng, L., et al. (2024) · Food Frontiers · doi:10.1002/fft2.498

Vitamins and Their Role in Alzheimer’s Disease

Joshi, D. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_19

Genome-wide association study identifies novel variants in olfactory, vitamin A, vitamin B, and cadherin pathways associated with learning and memory

Hopkins, L. N., Avgan, N., Sutherland, H. G. E., Fernandez, F., Knowles, E. E. M., Haupt, L. M., Blangero, J., Glahn, D. C., Shum, D., Lea, R. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32828-8

Stratégie de prévention de la maladie d'Alzheimer : Étude du rôle de la vitamine A

Biyong, E. F. (2019) · theses.fr (ABES) · doi:10.70675/e2ddd5cfz49a1z4980z8c8bzb97b1707e8df

Connecting mechanistic roles of vitamins in dementia: An overview on translational insights from preclinical models to clinical promise

Karmakar, V., Ghosh, A., Majie, A., Chatterjee, K., & Gorain, B. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103262

Carotenoids as Multifunctional Nutritional Modulators in Alzheimer’s Disease: A Mini‑Review of Parallel Effects on Oxidative Stress, Connexin 43, and Amyloid‑β Aggregation

Mathews, J. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr50580

BindingDB Entry 50016131: The protective effects of natural product tunicatachalcone against neuroinflammation via targeting RIPK2 in microglia BV-2 cells stimulated by LPS.

BindingDB (2023) · UC San Diego · doi:10.7270/q29s1w1x

Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease

Ray, S., Das, B. C., & Dasgupta, S. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.259604 · Cited by 90 · see citing works

Retinoids as potential targets for Alzheimer's disease

Sodhi, R. K., & Singh, N. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.016 · Cited by 91 · see citing works

Therapeutic insights elaborating the potential of retinoids in Alzheimer’s disease

Behl, T., Kaur, D., Sehgal, A., Singla, R. K., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976799 · Cited by 42 · see citing works

All-trans retinoic acid in Alzheimer's disease

Beheshti, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00035-5 · Cited by 2 · see citing works

How could retinoids fit into Alzheimer's therapy?

Steardo, L., Signorile, A., Scuderi, C., & Carratù, M. R. (2016) · Drugs of the Future · doi:10.1358/dof.2016.041.01.2401820 · Cited by 3 · see citing works